Background: In Arab and Muslim-dominated countries, spirituality and religiosity shape the belief and practices toward chronic illnesses. No previous studies were published to assess adherence to and satisfaction with antipsychotic medications in persons with schizophrenia in the Arab world.
INTRODUCTION
Schizophrenia is a chronic psychiatric disorder that impairs the quality of patients' lives [1] [2] [3] . Antipsychotic drug therapy has been reported to successfully minimize the frequency of acute schizophrenic episodes and hospitalization [4] . Adherence is a necessary element to achieve such success [4, 5] . Furthermore, adherence has been reported to lead to *Address correspondence to this author at the Department of Pharmacology and Toxicology, School of Pharmacy, An-Najah National University, Nablus, Palestine; Tel: 00-972-599-675-501; E-mails: ansam@najah.edu, ansam@ymail.com considerable cost savings for the health system [6] . However, nonadherence to antipsychotic medications is common and is considered as an integral barrier to the successful treatment of schizophrenia [7] [8] [9] . Several factors can contribute to medication non adherence in patients with schizophrenia [10] [11] [12] [13] . Such factors include race, culture and religion. For example, a review article about psychotropic medications found that rates of nonadherence were higher among Latinos than Euro-Americans and clinical and research interventions to improve adherence should be culturally appropriate and incorporate identified factors [14] . Another study examined how religious beliefs and practices can affect medication and illness representations in chronic
